Journal
BIOMEDICINES
Volume 10, Issue 6, Pages -Publisher
MDPI
DOI: 10.3390/biomedicines10061240
Keywords
inflammation; oxidative stress; Amyloid beta; total tau; immunoassays; middle-age; plasma
Categories
Funding
- NHMRC [973302, 179805, 157125, 1063907, 568969]
- ARC [120100227, FL190100011]
- Australian Research Council [FL190100011] Funding Source: Australian Research Council
Ask authors/readers for more resources
Inflammation and oxidative stress are associated with the development of Alzheimer's disease. In middle-age individuals, oxidative stress is associated with tau levels. In older-age individuals, oxidative stress is only associated with tau, while another component related to heightened inflammation is associated with all AD biomarkers.
Neuroinflammation and oxidative stress (OS) are implicated in the pathophysiology of Alzheimer's disease (AD). However, it is unclear at what stage of the disease process inflammation first becomes manifest. The aim of this study was to investigate the associations between specific plasma markers of inflammation and OS, tau, and Amyloid-beta 38, 40, and 42 levels in cognitively unimpaired middle-age and older individuals. Associations between inflammatory states identified through principal component analysis and AD biomarkers were investigated in middle-age (52-56 years, n = 335, 52% female) and older-age (72-76 years, n = 351, 46% female) participants without dementia. In middle-age, a component reflecting variation in OS was most strongly associated with tau and to a lesser extent amyloid-beta levels. In older-age, a similar component to that observed in middle-age was only associated with tau, while another component reflecting heightened inflammation independent of OS, was associated with all AD biomarkers. In middle and older-age, inflammation and OS states are associated with plasma AD biomarkers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available